ÂÜÀòÂÒÂ×

Patrick Bilbo has served as Chief Operating Officer since 2017. Previously, he served as Senior Vice President, Regulatory, Government Affairs and Administration and other executive positions from 1999 to 2017. His career in regenerative medicine, biotechnology and medical devices spans more than 30 years, and he has had a technical and leadership role in the successful development and commercialization of numerous products. Prior to joining Organogenesis, he held management and research positions at Hologic Corporation (Cytyc), Stryker Corporation and Harvard Medical School. Mr. Bilbo earned an M.B.A. from the Boston University Questrom School of Business, and Masters Degrees in Biology and Technology Strategy & Policy from the Boston University Graduate School of Arts & Sciences, and a B.S. degree in Biology from Syracuse University.